Abstract
Disease and drug-related alterations in the brain membrane proteome are of particular interest for investigations into neuropsychiatric disorders. Despite decades of research into neurotransmitters and their receptors, our understanding of complex neuropsychiatric disorders has failed to advance substantially. Therefore, global membrane protein profiling studies that are non-hypothesis driven and exploratory are a complementary approach to elucidate the underlying pathomechanisms associated with psychiatric disorders. Although membrane proteins play critical roles in almost all cellular processes, their unique biochemical properties have challenged current quantitative proteomics approaches. The aim of the present review is to critically evaluate and discuss the use and applicability of current quantitative proteomic platforms, sample preparation methods and statistical tools in view of their application to membrane proteome analysis of brain tissue.
Keywords: Neuropsychiatric disorders, quantitative proteomics, membrane proteins, brain tissue
Current Proteomics
Title: Quantitative Proteomic Approaches to Investigate the Membrane Proteome in Neuropsychiatric Disorders
Volume: 4 Issue: 3
Author(s): Man K. Chan and Sabine Bahn
Affiliation:
Keywords: Neuropsychiatric disorders, quantitative proteomics, membrane proteins, brain tissue
Abstract: Disease and drug-related alterations in the brain membrane proteome are of particular interest for investigations into neuropsychiatric disorders. Despite decades of research into neurotransmitters and their receptors, our understanding of complex neuropsychiatric disorders has failed to advance substantially. Therefore, global membrane protein profiling studies that are non-hypothesis driven and exploratory are a complementary approach to elucidate the underlying pathomechanisms associated with psychiatric disorders. Although membrane proteins play critical roles in almost all cellular processes, their unique biochemical properties have challenged current quantitative proteomics approaches. The aim of the present review is to critically evaluate and discuss the use and applicability of current quantitative proteomic platforms, sample preparation methods and statistical tools in view of their application to membrane proteome analysis of brain tissue.
Export Options
About this article
Cite this article as:
Chan K. Man and Bahn Sabine, Quantitative Proteomic Approaches to Investigate the Membrane Proteome in Neuropsychiatric Disorders, Current Proteomics 2007; 4 (3) . https://dx.doi.org/10.2174/157016407783221321
DOI https://dx.doi.org/10.2174/157016407783221321 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Sleep-Wake Patterns and Cognition of Older Adults with Amnestic Mild Cognitive Impairment (aMCI): A Comparison with Cognitively Healthy Adults and Moderate Alzheimer’s Disease Patients
Current Alzheimer Research Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease
Current Neurovascular Research Molecular Genetic of Human Male Infertility: From Genes to New Therapeutic Perspectives
Current Pharmaceutical Design Neuropeptides in Psychiatric Diseases: An Overview with a Particular Focus on Depression and Anxiety Disorders
CNS & Neurological Disorders - Drug Targets Cell Dormancy and Tumor Refractory
Anti-Cancer Agents in Medicinal Chemistry A Systematic Review of Current Progresses in the Nucleic Acid-Based Therapies for Neurodegeneration with Implications for Alzheimer’s Disease
Mini-Reviews in Medicinal Chemistry Development and Production of Commercial Therapeutic Monoclonal Antibodies in Mammalian Cell Expression Systems: An Overview of the Current Upstream Technologies
Current Pharmaceutical Biotechnology Smoking and Weight
Current Respiratory Medicine Reviews Imatinib (STI571) Resistance in Chronic Myelogenous Leukemia: Molecular Basis of the Underlying Mechanisms and Potential Strategies for Treatment
Mini-Reviews in Medicinal Chemistry New Insights into the Biology of 1-Antitrypsin and its Role in Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews Author Index to Volume 1
Current Alzheimer Research Pulmonary Rehabilitation as Evaluated by Clinical Trials: An Overview
Reviews on Recent Clinical Trials Hyperhomocysteinemia in Movement Disorders: Current Evidence and Hypotheses
Current Vascular Pharmacology Optimizing Modifiable and Lifestyle-related Factors in the Prevention of Dementia Disorders with Special Reference to Alzheimer, Parkinson and Autism Diseases
Current Nutrition & Food Science Computational Study of Human Tyrosine Hydroxylase Mutants to Uphold [4-(Propan-2-yl) Phenyl]Carbamic Acid as a Potential Inhibitor
CNS & Neurological Disorders - Drug Targets The Role of 5-HT3 Receptors in Drug Abuse and as a Target for Pharmacotherapy
CNS & Neurological Disorders - Drug Targets Subject Index To Volume 2
Current Bioactive Compounds Comparison of Glucocorticoid Receptor- and Epigenetically Regulated Genes in Proliferating Versus Growth-Arrested Neuro-2a Cells
CNS & Neurological Disorders - Drug Targets Biochemical Aspects of Nitric Oxide
Current Pharmaceutical Design New Trends in Medicinal Chemistry Approaches to Antiobesity Therapy
Current Topics in Medicinal Chemistry